ECR 2017 Press Talk - Siemens 2017 Press Talk. ... OB-GYN Cardiology Oncology Rehab ... Immunoassay, Chemistry, Hematology, Hemostasis, Specialty Testing, Automation,

Restricted © Siemens Healthcare GmbH, 2016Unrestricted © Siemens Healthcare GmbH, 2016

ECR 2017Press Talk

Page 2 | Unrestricted © Siemens Healthcare GmbH, 2017

Global Dynamics in Healthcare

Healthcare Trends

Demographic shift

Population growth

Rapid scientific progressStaff shortage

Shift to value-basedreimbursement

Growing chronicdisease burden

Increasing cost pressure

Consumerism

Managing HealthValue-based healthcare

ConsolidationBuilding the critical mass

IndustrializationDoing more with less

Transformation of Healthcare Providers


Providers today need suppliers / partners thatunderstand C-level challenges and address broad issues

How to win: Ability to solve system-widechallenges with relevance for C-suite

Emergency OR

Outpatient OrthopedicsOB-GYN Cardiology

Oncology RehabRadiology Laboratory

Single Hospital

Cons

olid

atio

n

Health Management

Industrialization

• Department /specialty focus

• Clinicians drivepurchase decisions

• Length of stay not alarge concern

• Volume-basedincentives

• System-wide focus• Typical challenges:

Minimize length ofstay, reduce re-admissions, …

• Team-based care• Quality / outcome-

based performanceincentives

Healthcare 20 years ago Healthcare today

How to win: Most innovativetechnologies on a department level

Race for Relevance

C-Suite

Multi-hospital provider systems


Outcomes

Costs

Our Purpose is toMake Healthcare Providers Succeed

Enablingbetter outcomes

atlower costs


> €1 bnR&D spent

75countries

with directpresence

>209,000patients

every hour2

Biggestsupplier

of medtechinfrastructure

Worldmarketleader

in mostbusinesses

> 46,000employees

12,500granted patents

globally

> 70%of critical clinical

decisionsare influenced by the

type of technologywe provide1

~ €13 bnrevenue

Access for

1.08 bnpeoplein developing

countries2

Who We Are

1 AdvaMedDX, “A Policy Primer on Diagnostics”, June 2011, page 32 Siemens AG, “Sustainable healthcare strategy - Indicators in fiscal 2014”, page 3-4


OurInnovations:transforminghealthcare


Future

1956CLINISTIX −dry chemistrytesting forglucose inurine

E.v. BehringW. C. Röntgen

1901Nobel prize winners (Physics + Medicine)

1896Industriallymanufac-tured X-rayappliance formedicaldiagnostics

1998First Siemenstrack-basedlaboratoryautomationsystem1967

Firstreal-timeultrasoundscanner

1975FirstSiemensCT scanner

1983First SiemensMRI scanner

2008Robotic-assistedangiographysystem

2009Multi-modality3D imagingnetwork

2008Digital

radiography,wireless flat

paneldetector 2012

Wirelesstransducersfor ultrasound

2014“Free breathing”

CT scanningwith dual X-ray

sources & detectorsDigitalHealth

Services

EnterpriseServices

AdvancedTherapies

1999First

intuitivemedical IT

platformfrom

Siemens

2001FirstPET/CTsystem fromSiemens

2006Diagnosticanalyzerintegratingfour tech-nologiesin one system

2005First

Dual SourceCT scanner

1957Fullyautomateddiscretechemistryanalyzer forwhole bloodor serum

1982Firstacridiniumester basedchemilumin-escenceimmuno-assays

2015Wide-angle imageacquisition breast

tomosynthesis

2016Liquid biopsy

Our Innovations -120 Years Track Record

2011First integrated,simultaneouswhole-bodyMRI and PET

Outcomes

Costs

2014teamplay

2015First Twin Robotic X-ray scanner forenhanced patient care and productivity

2016Atellica Solution1

MolecularDiagnostics

1: System under FDA review and not CE marked. Not available for sale. Any features listed are part of the development design goals. Future availabilitycannot be guaranteed


clinicalexcellence

operationalefficiency

financialprofitability

We supportto raise …

Ultrasound

Advanced Therapies

Diagnostic Imaging

Laboratory Diagnostics

Point of Care

Services

Computed Tomography, MagneticResonance, Molecular Imaging,Radiography & Fluoroscopy, Imaging IT

Cardiology, InterventionalRadiology, RadiationOncology, Surgery

Cardiology,Radiology

Immunoassay, Chemistry, Hematology,Hemostasis, Specialty Testing, Automation,IT and Services, Molecular Diagnostics*

Blood Gas, DiabetesUrinalysis, Coagulation,Cardiology

System Services, Education,Enterprise Services,Digital Services

Engineering Success –With Broadest and Deepest Portfolio

Undisputed market leaderin diagnostic imaging

Empowering innovativetherapy concepts

Versatility and functionalityacross clinical questions

Delivering clinical andworkflow excellence

Lab-accurate, actionable,timely results at the point of care

Transformative services to maximizeopportunities and minimize risks

*Incubated within Business Function Strategy & InnovationImage courtesy Diagnostic Imaging: CMRR, Minneapolis, MGH, BostonImage courtesy Advanced Therapies: IHU Strasbourg, France


The first BioMatrix systemMAGNETOM Vida

New3T magnet

architecture

RevolutionaryBioMatrixTechnology

Reduced TCOwith efficient

energymanagement

UnparalleledGradient power

60/200simultaneously

Free-breathingabdominaland cardiac

imaging

Reproducibleresults

with GOworkflow

TechnologiesMagnetom Vida is pending 510(k) clearance, and is not yet commercially available in the United States orin other countries. Due to regulatory reasons, its future availability cannot be guaranteed.

Patient friendlydesign with

70 cm


Two iF Awards 2017 for ARTIS pheno and theSOMATOM go.Family

ARTIS pheno is pending 510(k) clearance, and is not yet commercially available in the United States or in other countries.Due to regulatory reasons, its future availability cannot be guaranteed.


Focus on user experience and design enables us todevelop the best solutions for our customers

Advanced Systems:Design transforming advanced robot technologyfor sensitive clinical environments

Intelligent WorkflowsImproving examinations

Patient-friendly Technology:Human-centered design forpatients and clinical staff


Atellica Solution – Game Changer in In-Vitro-Diagnostics

• Engineered based on our customers’ needs andextensive research of market trends

• Game changing solution delivering control andsimplicity for driving better business and clinicaloutcomes

• Patented, bi-directional magnetic sampletransport technology is 10 times faster thanconventional conveyors1)

• Immunoassay analyzer delivers the industry’shighest productivity per square meter2) — morethan 400 tests per hour

1) System under FDA review and not CE marked. Not available for sale. Any features listed are part of thedevelopment design goals. Future availability cannot be guaranteed. 2) Versus leading IVD marketcompetitors


Acquisitions to Strengthen Growth Areasand Broaden IVD Portfolio

• Expansion of Diagnostics and Molecular ServicesPortfolio with molecular testing related servicesand technologies for oncology and genomics

• Entry point into NGS-based genomic testing andexpanding capabilities in precision medicine andcompanion diagnostics

• Consolidation trend in healthcare , resulting inemerging healthcare networks ask for seamlessintegration of hundreds of decentralized devicesthat are spread across dozens of sites

• Common point-of care informatics portfoliodelivers open connectivity offerings, enablingseamless data integration from anymanufacturer’s point-of-care analyzer—managed by a single informatics solution tostreamline operations and access to data


OurServices:Transformingthe Managementof Health


Our Technology –The Nervous System for Healthcare Providers

Screening beforesymptoms

MonitoringchronicdiseasesDiagnosing disease

Triaging emergencies Personalizing care path

Minimizing risk

Guidingtreatment

Controlling response

Ensuringquality

Assessing resultsConfirminghealth

Screening beforesymptoms

Diagnosing diseaseTriaging emergencies

Monitoringchronicdiseases

Confirminghealth

> 70%of critical clinical

decisions influencedthe type of technology

we provide

2%of budget touching

almost every patient

covering all majordisease states

Prevention Diagnosis Therapy Care


syngo Enterprise Imaging ITsyngo Departmental

Imaging IT

Imaging IT

Transforming the Management of Healthcare –Through Digital Services

Reading marketplaceInterpretation services,Teleradiology platforms

command centers

TeleradiologyServices

Performance ManagementClinical Care Management

Patient Engagement &Monitoring Infrastructure

Clinical Data & Workflow Integration

PopulationHealth

Management

Teleradiology Services and Digital Ecosystem are work in progress, and is not yet commercially available in the United States or in other countries.Due to regulatory reasons, its future availability cannot be guaranteed.


Driving value in healthcare with theSiemens Healthineers Digital Ecosystem

Page 17 | Restricted © Siemens Healthcare GmbH, 2017Siemens Healthineers Digital Ecosystem is work in progress, and is not yet commercially available in the United States or in other countries.Due to regulatory reasons, its future availability cannot be guaranteed.


Siemens Healthineers and IBM Watson Healthpartner on Population Health Management (PHM)

The new alliance is to support healthcareproviders seeking to improve outcomesand reduce costsFive year, global strategic alliance in PHMto jointly develop innovative solutionsand services to expand portfolio

We will augment the existing IBM PHM offeringswith lab and imaging assets and servicesand will sell it into the global HealthcareProvider space


Asset Management ServicesStaffing and Capacity Services

Managed Departmental Services

EnterpriseOperationsas a Service

Transforming the Management of HealthcareThrough Enterprise Services

EnterpriseTransformation

and AdvisoryServices

Facility Design ServicesPerformance Improvement Services

Transformation Services


Business Model Innovation: "Bilkent" – largestManaged Lab Operations Services contract in Turkey

• Managed Lab Operations Services for all themedical laboratory disciplines

• Operational management with our technical staff

• Medical and technical equipment

• Reagents, consumables and necessary supplies

• Lab design, procurement, training, and ongoingprocess optimization are key value added services

• Some numbers:

• Laboratory services worth up to €100 millionEuros

• About 25.000 patients expected per day

• 3'5 peak monthly test volume


OurPeople:Transformingthe Industry


Our People –Engineers. Pioneers. Passionate for Healthcare.

1,474inventionsdisclosedin 2015

≥85%employee

engagement

“A day withoutpassion for

healthcare is alost day”

50%of employees

globallywith SiemensHealthineers

> 10 years92%of employees

committedto go the

“extra-mile”

7,660R&D employees

10%of employeeswith clinicalbackground

17% ofentire company


Q1 FY2017: Quarterly Results (in billions of €)

1) Comparable 2) Cash Conversion Rate

3.350

+4%comp.1)

3.451

Q1 FY 2016 Q1 FY 2017

Orders

0.541(16.5%)

+240 bps

0.620(18.9%)

3.2880%

comp.1) 3.282

0.2990.55

+15%

0.3450.56

Revenue

Free Cash FlowCCR2)

Profit Margin


FY2016: Annual Results (in billions of €)

1) Comparable 2) Without Special Impact 3) Cash Conversion Rate

13.349

+4%comp.1)

13.830

FY 2015 FY 2016

Orders

2.184(16.9%)

+70bps2.325

(17.2%)

12.930

+5%comp.1)

13.535

2.0480.94

+5%

2.1540.93

Revenue

Free Cash FlowCCR3)

2.185(16.9%)

2.386(17.6%)

Profit Marginw/o S.I.2)


Shanghai (China)

Expanding our local footprint in the biggest markets –New Laboratory Diagnostics factories in U.S. and China

Walpole (U.S.)

• Investment of $300'' in Walpole,Massachusetts

• Facility will manufacture assays for the next-generation laboratory system, the AtellicaTMSolution

• Up to 700 new, attractive jobs

• Expansion of existing manufacturingoperations to include a new in vitrodiagnostics facility

• In-country manufacturing capabilities forclinical chemistry and immunoassayreagents

• Several hundreds of additional employees


• Strengthen and build position in identified growth fields

• Providing highest degree of strategic execution flexibility

• Flexible access to capital markets

STRENGTHEN HEALTHINEERS BUSINESSIN SIEMENS

• Paradigm shifts visible: Transition from

- product business to solving hospitalsystem wide challenges

- fee for service to managing outcome based health

• Race for customer relevance intensified

• Competitor & provider consolidation ongoing

• Investments required to respond to paradigmshifts

Transformation in thehealthcare market continues… … listing best suited to manage transition

üüü

Preparing listing of Siemens Healthineers tostrengthen leadership position


Siemens Healthineers –Transforming the Way Healthcare is Delivered

@SiemensHealth

@bernd_montag

#Innovations

#FutureOfHealthcare#ManagingHealth

#Consolidation #PrecisionMedicine

#DigitalizationOfHealthcare

#Industrialization

#PopHealth


Disclaimer

DISCLAIMER

This document constitutes neither an offer to sell nor a solicitation to buy or subscribe for securities. Any such offer would be made solely on the basis ofthe Securities Prospectus to be published and registered with the German Financial Supervisory Authority (BaFin). The information legally required to beprovided to investors is contained only in the Securities Prospectus. The Securities Prospectus will be published as legally required at a time yet to bedetermined.

In particular, this document is not an offer of securities for sale in the United States of America. The securities have not been and will not be registeredunder the Securities Act and may not be offered or sold in the United States of America absent registration or an exemption from registration under theSecurities Act.

This document is also not an offer of securities for sale in the United Kingdom, Canada, Japan or Australia.

Restricted © Siemens Healthcare GmbH, 2016Unrestricted © Siemens Healthcare GmbH, 2016

ECR 2017Press Talk

Documents

ECR 2017 Press Talk - Siemens 2017 Press Talk. ... OB-GYN Cardiology Oncology Rehab ... Immunoassay, Chemistry, Hematology, Hemostasis, Specialty Testing, Automation,